Why the study?
The study was conducted to determine the frequency of anticardiolipin antibodies in women experiencing recurrent fetal loss.
Anticardiolipin antibody frequency in recurrent fetal loss is hypothesis-generating; leaves open clinical utility pending controlled studies.
Aim: To find out the frequency of Anticardiolipin Antibodies in women with recurrent fetal loss Study design & duration: One year descriptive study Methods: Seventy five females were included in the study with ages ranging from 20-40 years with minimum two miscarriages. Diabetic females and females with history of bacterial or viral diseases were excluded from the study. Results: In this group the mean age was 27.60±3.29 years. Mean number of fetal losses was 2.95±1.45 whereas mean duration of marriage was 5.79±4.11 years. Conclusion: It is suggested that the patient with history of recurrent miscarriages must be screened for Anticardiolipin Antibodies to bring them out of psychological and physical trauma.
No takes yet. Share an insight, caveat, or question.
Farooq et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: